Unbiased Analysis of Today's Healthcare Issues
That is the answer Caswell-Jin et al. (2024) aim to answer. The authors used 4 cancer mortality models within CISNET for this study: Model D (Dana-Farber Cancer Institute). Used to define a set of disease states and implemented analytic formulations to estimate the association of interventions on transitions between these states, as well as on…
A paper by Gupta and Akinyemiju (2024) uses SEER data to examine trends in age-adjusted cancer mortality between blacks and whites between 2000 and 2020. The authors find that: In 2000, the [age-adjusted mortality] rate was 251.7 per 100 000 population among Black individuals and 199.7 per 100 000 population among White individuals, decreasing to 166.8 per…
That is the title of a paper currently published (well, in pre-prints) at Value in Health. Co-authors include Jaehong Kim, Moises Marin MA, Sangeetha Ramsagar, Mark Lloyd Davies, Kyana Stewart, Iftekhar Kalsekar and Anil Vachani. The abstract is below: ObjectiveTo measure the value of increasing lung cancer screening rates for high-risk individuals and its impact…
According to a paper by Miljković et al. (2023), the answer is ‘no‘. The authors examine oncology treatments with FDA approvals between 2015 and 2020 and identify average wholesale prices from Redbook. Drugs were classified into three categories: (i) first approval of a new mechanism of action compound, (ii) next-in-class approval regardless the tumor type,…
That is the finding from a CDC report released this month. Mortality rates fell by 24% between 2001 and 2021. Specifically, the cancer death rate for youth ages 0–19 years was 2.75 per 100,000 in 2001, but decrease to 2.10 per 100,000 in 2021. The analysis uses data including (i) cause of death data from…
That is the finding from a Shih et al. (2023). Their first finding is that white bagging and brown bagging are not yet that common, with the exception of supportive care. However use of “bagging” does save money…for payers at least. Adjusted mean insurance payments PPPM [per patient per month] were statistically significantly lower for…
That is the topic of a recent paper Tyan, Lam and Milligan (2023). Using newly created database from financial databases combined with press releases, news sources, clinic websites, and financial 10-K reports, the authors found that: During 2003 to 2022, 724 oncology clinics (53% radiation, 32% medical, 15% multi-oncologic) became affiliated with a PE-backed platform…
What are the economic consequences of the updated USPSTF recommendations to move the age for annual breast cancer screening to age 40? I was interviewed at NPR’s Marketplace Morning Report today (May 11, 2023) to help answer the question. You can listen to the episode here (the segment on breast cancer screening starts at 5:32).…
An ambitious paper by Chen et al. (2023) published last week aim to estimate the economic burden of cancer across 204 countries between 2020 and 2050 . The authors find that cancer’s economic burden is equivalent to an annual tax of 0.55% of global GDP. The full results are below. The estimated global economic cost…
These are becoming increasingly common. Agrawal et al. (2022) use data between 2002-2021, and found that FDA approved: …176 new malignant hematology and oncology indications based on single-arm trials, including 116 accelerated approvals (AAs) and 60 traditional approvals. Overall, 87 approvals (49%) were for new molecular entities or original biologics and 89 (51%) were supplemental…